Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Gross Margin (2023 - 2025)

Historic Gross Margin for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to 80.0%.

  • Mereo BioPharma's Gross Margin changed N/A to 80.0% in Q2 2025 from the same period last year, while for Sep 2025 it was 125.0%, marking a year-over-year decrease of 23000.0%. This contributed to the annual value of 74.26% for FY2023, which is N/A changed from last year.
  • Per Mereo BioPharma's latest filing, its Gross Margin stood at 80.0% for Q2 2025.
  • In the past 5 years, Mereo BioPharma's Gross Margin registered a high of 127.3% during Q4 2023, and its lowest value of 61.89% during Q2 2023.